PSA-stratified detection rates for [68Ga]THP-PSMA, a novel probe for rapid kit-based 68Ga-labeling and PET imaging, in patients with biochemical recurrence after primary therapy for prostate cancer

التفاصيل البيبلوغرافية
العنوان: PSA-stratified detection rates for [68Ga]THP-PSMA, a novel probe for rapid kit-based 68Ga-labeling and PET imaging, in patients with biochemical recurrence after primary therapy for prostate cancer
المؤلفون: Sebastian Schmuck, Frank M. Bengel, Christoph A. J. von Klot, Christoph Henkenberens, Hans Christiansen, Cathleen Juhl, Thorsten Derlin, Johanna Zörgiebel, Sophie M. Schneefeld, Katja Hueper, Tobias L. Ross, James T. Thackeray, Almut Walte
المصدر: European Journal of Nuclear Medicine and Molecular Imaging. 45:913-922
بيانات النشر: Springer Science and Business Media LLC, 2018.
سنة النشر: 2018
مصطلحات موضوعية: Biochemical recurrence, PET-CT, medicine.medical_specialty, medicine.diagnostic_test, Prostatectomy, business.industry, medicine.medical_treatment, Urology, General Medicine, urologic and male genital diseases, medicine.disease, 030218 nuclear medicine & medical imaging, Androgen deprivation therapy, 03 medical and health sciences, Prostate-specific antigen, Prostate cancer, 0302 clinical medicine, Positron emission tomography, 030220 oncology & carcinogenesis, medicine, Radiology, Nuclear Medicine and imaging, Prospective cohort study, business
الوصف: [68Ga]Tris(hydroxypyridinone)(THP)-PSMA is a novel radiopharmaceutical for one-step kit-based radiolabelling, based on direct chelation of 68Ga3+ at low concentration, room temperature and over a wide pH range, using direct elution from a 68Ge/68Ga-generator. We evaluated the clinical detection rates of [68Ga]THP-PSMA PET/CT in patients with biochemically recurrent prostate cancer after prostatectomy. Consecutive patients (n=99) referred for evaluation of biochemical relapse of prostate cancer by [68Ga]THP-PSMA PET/CT were analyzed retrospectively. Patients underwent a standard whole-body PET/CT (1 h p.i.), followed by delayed (3 h p.i.) imaging of the abdomen. PSA-stratified cohorts of positive PET/CT results, standardized uptake values (SUVs) and target-to-background ratios (TBRs) were analyzed, and compared between standard and delayed imaging. At least one lesion suggestive of recurrent or metastatic prostate cancer was identified on PET images in 52 patients (52.5%). Detection rates of [68Ga]THP-PSMA PET/CT increased with increasing PSA level: 94.1% for a PSA value of ≥10 ng/mL, 77.3% for a PSA value of 2 to 0.2 to
تدمد: 1619-7089
1619-7070
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::58bd3921fdd85ee85afeed073b6dad00
https://doi.org/10.1007/s00259-017-3924-9
حقوق: CLOSED
رقم الأكسشن: edsair.doi...........58bd3921fdd85ee85afeed073b6dad00
قاعدة البيانات: OpenAIRE